Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

GEMP

Gemphire Therapeutics (GEMP)

Gemphire Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GEMP
FechaHoraFuenteTítuloSímboloCompañía
31/12/201905:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201910:22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201910:08GlobeNewswire Inc.Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
06/12/201915:25Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
06/12/201907:43GlobeNewswire Inc.Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201908:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
07/11/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
06/11/201908:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
04/11/201915:27Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/09/201905:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201916:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
05/08/201907:22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
26/07/201915:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
24/07/201915:01GlobeNewswire Inc.Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease CompanyNASDAQ:GEMPGemphire Therapeutics Inc
16/07/201915:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GEMPGemphire Therapeutics Inc
26/06/201907:00GlobeNewswire Inc.Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Tri...NASDAQ:GEMPGemphire Therapeutics Inc
18/03/201905:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GEMPGemphire Therapeutics Inc
15/03/201907:00GlobeNewswire Inc.Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial ResultsNASDAQ:GEMPGemphire Therapeutics Inc
14/02/201915:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/12/201807:00GlobeNewswire Inc.Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201815:01GlobeNewswire Inc.Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
24/09/201816:06GlobeNewswire Inc.Gemphire Therapeutics Announces Workforce ReductionNASDAQ:GEMPGemphire Therapeutics Inc
28/08/201809:05Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:GEMPGemphire Therapeutics Inc
22/08/201815:51Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
20/08/201815:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201815:01GlobeNewswire Inc.Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201810:33Dow Jones NewsGemphire Therapeutics Shares Fall Over 50% in Heavy Trading -- Market MoverNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201805:00GlobeNewswire Inc.Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLDNASDAQ:GEMPGemphire Therapeutics Inc
06/08/201815:01GlobeNewswire Inc.Gemphire Announces Amended and Restated Gemcabene License Agreement with Pfizer Inc.NASDAQ:GEMPGemphire Therapeutics Inc
06/08/201815:01GlobeNewswire Inc.Gemphire Provides Update On Development of GemcabeneNASDAQ:GEMPGemphire Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GEMP

Su Consulta Reciente

Delayed Upgrade Clock